BlackRock Institutional Trust’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$15.4M	Buy	2,620,238 +31,625	+1%	+$173K	﹤0.01%	2151
2016 Q3	$13.7M	Buy	2,588,613 +175,601	+7%	+$947K	﹤0.01%	2134
2016 Q2	$16M	Sell	2,413,012 -214,462	-8%	-$1.2M	﹤0.01%	1993
2016 Q1	$12.3M	Buy	2,627,474 +4,057	+0.2%	+$16.2K	﹤0.01%	2134
2015 Q4	$13.2M	Buy	2,623,417 +76,006	+3%	+$361K	﹤0.01%	2140
2015 Q3	$8.97M	Buy	2,547,411 +60,599	+2%	+$406K	﹤0.01%	2364
2015 Q2	$24.8M	Sell	2,486,812 -125,582	-5%	-$1.35M	﹤0.01%	1772
2015 Q1	$33.3M	Buy	2,612,394 +193,055	+8%	+$2.48M	0.01%	1590
2014 Q4	$34.2M	Sell	2,419,339 -121,588	-5%	-$1.88M	0.01%	1551
2014 Q3	$34.9M	Sell	2,540,927 -13,084	-0.5%	-$200K	0.01%	1505
2014 Q2	$39.3M	Sell	2,554,011 -6,449	-0.3%	-$91.4K	0.01%	1488
2014 Q1	$43.6M	Buy	2,560,460 +166,953	+7%	+$2.52M	0.01%	1386
2013 Q4	$31M	Sell	2,393,507 -40,958	-2%	-$489K	0.01%	1606
2013 Q3	$24.6M	Buy	2,434,465 +150,572	+7%	+$1.34M	﹤0.01%	1707
2013 Q2	$17.1M	Buy	+2,283,893	New	+$17.8M	﹤0.01%	1925